June 22 (Reuters) - Regenxbio (RGNX.O), opens new tab said on Monday the U.S. FDA has indicated that existing data for its rare-disease gene therapy could support an accelerated approval application, ...
US FDA Reverses Course on Regenxbio's Rare-Disease Gene Therapy, Backs Accelerated Approval Bid By Siddhi Mahatole June 22 (Reuters) - Regenxbio said on Monday the U.S. FDA has indicated that ...
The FDA has pulled a U-turn on uniQure’s Huntington’s disease gene therapy, giving the biotech the OK to file for accelerated approval after previously demanding data from another trial. After ...
In another sign that the FDA is easing its stance toward rare disease drug candidates under new leadership, the agency will reconsider Regenxbio’s gene therapy for an ultra-rare childhood disease, a ...
FDA says three-year trial data could support accelerated approval filing Agency drops demand for new sham-surgery trial Shares surge over 75% June 17 (Reuters) - UniQure (UQ1.F), opens new tab, said ...
The ELIMINATE trial: A phase II/III randomized trial evaluating omission of radiotherapy to regional lymphatics in pN0/N1 neck for oral cavity carcinomas. Background: Postoperative radiotherapy (PORT) ...
Do you know that most issues related to anxiety, depression, and addiction are symptoms of deeper underlying causes? Do you find yourself constantly slipping into unhealthy patterns and behaviors or ...
Through PGA TOUR University Accelerated, a high-achieving junior, sophomore or freshman can earn PGA TOUR membership and become eligible for all open, full-field TOUR events. Players earn points based ...
Washington — The Senate on Tuesday approved a House-passed resolution aimed at reining in President Trump on Iran, marking the first time such a measure has made it through both chambers and ...
June 17 (Reuters) - UniQure said the U.S. health regulator has agreed existing trial data could support a filing for accelerated approval of its Huntington's treatment, sending the Dutch drugmaker's U ...
Hosted on MSN
US FDA reverses course on Regenxbio's rare-disease gene therapy, backs accelerated approval bid
June 22 (Reuters) - Regenxbio said on Monday the U.S. FDA has indicated that existing data for its rare-disease gene therapy could support an accelerated approval application, reversing course months ...
The United States Senate has voted in favour of invoking its war powers to force President Donald Trump to halt his military campaign against Iran or seek congressional approval before any further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results